Sign In
Buy BNTX
$89.59
+1.14 (+1.29%)
At Close: Jun 04, 2026
Moderna Sues Pfizer And BioNTech Over Covid-19 Vaccine
09:37am, Friday, 26'th Aug 2022
The company says Pfizer and BioNTech copied Moderna's mRNA technology without its permission.
Moderna Claims Pfizer, BioNTech Stole Its Patented Tech In Covid Shot
09:27am, Friday, 26'th Aug 2022
Moderna is suing Pfizer and BioNTech for patent infringement, claiming the duo copied its mRNA technology. All three vaccine stocks fell.
Moderna sues Pfizer and BioNTech for patent infringement relating to the mRNA platform used to develop COVID vaccines
08:14am, Friday, 26'th Aug 2022
Moderna Inc. MRNA, +0.44% said Friday it is suing Pfizer Inc. PFE, +0.99% and German partner BioNTech SE BNTX, +1.59% for infringing patents relating to its mRNA platform, the source of the COVID vacc
Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine
08:08am, Friday, 26'th Aug 2022
Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that Mod
Omicron-targeting COVID boosters may be out after Labor Day, and Moderna has joined Pfizer and BioNTech in filing for authorization
10:30am, Thursday, 25'th Aug 2022 MarketWatch
Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day, according to a new report.
Omicron-targeting COVID boosters may be out after Labor Day, and Moderna has joined Pfizer and BioNTech in filing for authorization
10:06am, Wednesday, 24'th Aug 2022
Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day, according to a new report.
Here's Why This Dominant Income Stock Is a Buy
05:30am, Wednesday, 24'th Aug 2022
This company is the undisputed leader in COVID-19 vaccines and treatments.
Pfizer-BioNTech Covid Vaccine Is 73% Effective In Young Children, Study Finds
10:40am, Tuesday, 23'rd Aug 2022
The three-dose vaccine was most effective in children ages 6 months to 2 years, with a 75.8% efficacy rate, according to the study.
Pfizer and BioNTech say data shows COVID vaccine has more than 70% efficacy in small children, and cases now rising in just 7 states
10:04am, Tuesday, 23'rd Aug 2022
Pfizer and German partner BioNTech on Tuesday offered updated COVID vaccine data supporting efficacy in children aged 6 months through 4 years of age.
Pfizer and BioNTech say COVID vaccine data showed 73.2% efficacy among children aged 6 month to 4 years
06:54am, Tuesday, 23'rd Aug 2022
Pfizer Inc. PFE, -0.51% and German partner BioNTech SE BNTX, +0.26% on Tuesday announced updated COVID vaccine data supporting efficacy in children aged 6 months through 4 years of age. The companies
Pfizer, BioNTech complete FDA submission for new COVID-19 booster
10:45am, Monday, 22'nd Aug 2022
Pfizer Inc. PFE, -0.36% and BioNTech SE BNTX, +0.21% said Monday that they formally completed an application asking the Food and Drug Administration to authorize their experimental bivalent COVID-19 b
1 Hot Growth Stock to Buy, and 1 to Avoid (For Now)
09:45am, Monday, 15'th Aug 2022
Pfizer's diversified portfolio of medicines will ensure it keeps outperforming BioNTech.
Is This Battered Growth Stock Still a Buy After Its Latest Stumble?
08:30am, Thursday, 11'th Aug 2022
Its flagship vaccine product isn't selling as much as it used to.
Why BioNTech Was Tumbling Again Today
03:25pm, Tuesday, 09'th Aug 2022
Fresh analyst price target cuts dampen investor sentiment on the biotech stock.
Why BioNTech Was a Sickly Stock on Monday
03:20pm, Monday, 08'th Aug 2022
The company's top and bottom lines both declined considerably in the second quarter.
